IA
BNGO icon

Inspire Advisors’s Bionano Genomics BNGO Stock Holding History

Inspire Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-487
Closed -$8.43K – 461
2024
Q4 		$8.43K Sell
487
-134
-22% -$2.29K ﹤0.01% 415
2024
Q3 		$16.9K Sell
621
-40
-6% -$1.24K ﹤0.01% 421
2024
Q2 		$26.9K Buy
661
+84
+15% +$4.62K ﹤0.01% 372
2024
Q1 		$38.4K Sell
577
-31
-5% -$2.31K 0.01% 369
2023
Q4 		$68.9K Sell
608
-52
-8% -$5.43K 0.01% 331
2023
Q3 		$120K Buy
660
+2
+0.3% +$524 0.02% 259
2023
Q2 		$241K Buy
658
+34
+5% +$15.3K 0.05% 200
2023
Q1 		$415K Buy
624
+11
+2% +$9.77K 0.1% 86
2022
Q4 		$537K Sell
613
-55
-8% -$69.2K 0.14% 49
2022
Q3 		$733K Sell
668
-4
-0.6% -$5.29K 0.2% 18
2022
Q2 		$557K Buy
672
+57
+9% +$58.6K 0.16% 23
2022
Q1 		$952K Buy
615
+45
+8% +$60.7K 0.27% 12
2021
Q4 		$1.02M Sell
570
-56
-9% -$150K 0.29% 14
2021
Q3 		$2.07M Buy
626
+30
+5% +$105K 0.65% 11
2021
Q2 		$2.62M Buy
596
+110
+23% +$434K 0.85% 12
2021
Q1 		$2.36M Buy
486
+483
+16,100% +$2.72M 0.85% 10
2020
Q4 		$6K Buy
+3
New +$1.12K ﹤0.01% 574

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Inspire Advisors's BNGO Position: Q1 2025 in Review

Inspire Advisors sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 487 shares — an estimated $8.43K sold.

Inspire Advisors first reported a position in BNGO in Q4 2020 and held it in 17 quarters. The position peaked at $2.62M in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Inspire Advisors reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Inspire Advisors sold 487 Bionano Genomics shares in Q1 2025, an estimated $8.43K.
  • Inspire Advisors first reported a position in Bionano Genomics in Q4 2020 and held it in 17 quarters.
  • Inspire Advisors's Bionano Genomics position peaked at $2.62M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Inspire Advisors's 13F filing for Q1 2025, filed 7 May 2025.